Correlation Between Unicycive Therapeutics and Sirius

Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Sirius at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Sirius into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Unicycive Therapeutics and Sirius XM Holdings, you can compare the effects of market volatilities on Unicycive Therapeutics and Sirius and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Sirius. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Sirius.

Diversification Opportunities for Unicycive Therapeutics and Sirius

-0.7

Correlation Coefficient

Unicycive Therapeutics  Sirius

Excellent diversification

The 3 months correlation between Unicycive and Sirius is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Sirius XM Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sirius XM Holdings and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Sirius. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sirius XM Holdings has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Sirius go up and down completely randomly.

Pair Corralation between Unicycive Therapeutics and Sirius

Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 14.72 times more return on investment than Sirius. However, Unicycive Therapeutics is 14.72 times more volatile than Sirius XM Holdings. It trades about 0.04 of its potential returns per unit of risk. Sirius XM Holdings is currently generating about 0.02 per unit of risk. If you would invest  61.00  in Unicycive Therapeutics on October 12, 2024 and sell it today you would earn a total of  5.00  from holding Unicycive Therapeutics or generate 8.2% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	99.19%
Values	Daily Returns

Unicycive Therapeutics  vs.  Sirius XM Holdings

Unicycive Therapeutics

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Unicycive Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Unicycive Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Sirius XM Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sirius XM Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Sirius is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Unicycive Therapeutics and Sirius

The main advantage of trading using opposite Unicycive Therapeutics and Sirius positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Sirius can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sirius will offset losses from the drop in Sirius' long position.

The idea behind Unicycive Therapeutics and Sirius XM Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.